Table of Contents
Journal of Biomarkers
Volume 2015 (2015), Article ID 981458, 16 pages
http://dx.doi.org/10.1155/2015/981458
Review Article

Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer

Biomedical Science Research Centre, School of Environment and Life Sciences, University of Salford, Manchester M5 4WT, UK

Received 25 September 2014; Accepted 10 March 2015

Academic Editor: Ranju Ralhan

Copyright © 2015 Kamila Schmidt and Ian Podmore. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, World Cancer Report 2008, edited by P. Boyle and B. Levin, IARC Press, Lyon, France, 2008.
  2. R. K. Portenoy, H. T. Thaler, A. B. Kornblith et al., “Symptom prevalence, characteristics and distress in a cancer population,” Quality of Life Research, vol. 3, no. 3, pp. 183–189, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Young, J. A. Toretsky, A. B. Campbell, and A. E. Eskenazi, “Recognition of common childhood malignancies,” American Family Physician, vol. 61, no. 7, pp. 2144–2154, 2000. View at Google Scholar · View at Scopus
  4. J. A. de Barros, G. Valladares, A. R. Faria et al., “Early diagnosis of lung cancer: the great challenge. Epidemiological variables, clinical variables, staging and treatment,” Jornal Brasileiro de Pneumologia, vol. 32, no. 3, pp. 221–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. K. Gupta, D. E. Brenner, and D. K. Turgeon, “Early detection of colon cancer: new tests on the horizon,” Molecular Diagnosis & Therapy, vol. 12, no. 2, pp. 77–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. NLSTRT (The National Lung Screening Trial Research Team), “Reduced lung-cancer mortality with low-dose computed tomographic screening,” The New England Journal of Medicine, vol. 365, no. 5, pp. 395–409, 2011. View at Publisher · View at Google Scholar
  7. J. D. Brooks, “Translational genomics: the challenge of developing cancer biomarkers,” Genome Research, vol. 22, no. 2, pp. 183–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. R. D. Beger, “A review of applications of metabolomics in cancer,” Metabolites, vol. 3, no. 3, pp. 552–574, 2013. View at Publisher · View at Google Scholar
  9. A. Khadir and A. Tiss, “Proteomics approaches towards early detection and diagnosis of cancer,” Journal of Carcinogenesis & Mutagenesis, supplement 14, article 002, 16 pages, 2013. View at Google Scholar
  10. WHO, Indoor Air Quality: Organic Pollutants. Report on a WHO Meeting, Berlin (West) 23–27 August 1987, World Health Organization Regional Office for Europe, Copenhagen, Denmark, 1989.
  11. L. Pauling, A. B. Robinson, R. Teranishi, and P. Cary, “Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 10, pp. 2374–2376, 1971. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Deng and X. Zhang, “A simple, rapid and sensitive method for determination of aldehydes in human blood by gas chromatography/mass spectrometry and solid-phase microextraction with on-fiber derivatization,” Rapid Communications in Mass Spectrometry, vol. 18, no. 15, pp. 1715–1720, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Ahmed, R. Greenwood, B. de Lacy Costello, N. M. Ratcliffe, and C. S. Probert, “An investigation of fecal volatile organic metabolites in irritable bowel syndrome,” PLoS ONE, vol. 8, no. 3, Article ID e58204, 2013. View at Publisher · View at Google Scholar
  14. M. Gallagher, C. J. Wysocki, J. J. Leyden, A. I. Spielman, X. Sun, and G. Preti, “Analyses of volatile organic compounds from human skin,” British Journal of Dermatology, vol. 159, no. 4, pp. 780–791, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Filipiak, A. Sponring, T. Mikoviny et al., “Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro,” Cancer Cell International, vol. 8, article 17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. H. J. O'Neill, S. M. Gordon, M. H. O'Neill, R. D. Gibbons, and J. P. Szidon, “A computerized classification technique for screening for the presence of breath biomarkers in lung cancer,” Clinical Chemistry, vol. 34, no. 8, pp. 1613–1618, 1988. View at Google Scholar · View at Scopus
  17. B. Ibrahim, M. Basanta, P. Cadden et al., “Non-invasive phenotyping using exhaled volatile organic compounds in asthma,” Thorax, vol. 66, no. 9, pp. 804–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Barker, M. Hengst, J. Schmid et al., “Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis,” European Respiratory Journal, vol. 27, no. 5, pp. 929–936, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Phillips, R. N. Cataneo, T. Cheema, and J. Greenberg, “Increased breath biomarkers of oxidative stress in diabetes mellitus,” Clinica Chimica Acta, vol. 344, no. 1-2, pp. 189–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Phillips, R. N. Cataneo, R. Condos et al., “Volatile biomarkers of pulmonary tuberculosis in the breath,” Tuberculosis, vol. 87, no. 1, pp. 44–52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. O. Phillips, Y. Syed, N. M. Parthaláin, R. Zwiggelaar, T. C. Claypole, and K. E. Lewis, “Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls,” Journal of Breath Research, vol. 6, no. 3, Article ID 036003, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Phillips, J. P. Boehmer, R. N. Cataneo et al., “Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study),” Journal of Heart and Lung Transplantation, vol. 23, no. 6, pp. 701–708, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Cao and Y. Duan, “Breath analysis: potential for clinical diagnosis and exposure assessment,” Clinical Chemistry, vol. 52, no. 5, pp. 800–811, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. E. Szulejko, M. McCulloch, J. Jackson, D. L. McKee, J. C. Walker, and T. Solouki, “Evidence for cancer biomarkers in exhaled breath,” IEEE Sensors Journal, vol. 10, no. 1, pp. 185–210, 2010. View at Publisher · View at Google Scholar
  25. P. Mochalski, J. King, M. Haas, K. Unterkofler, A. Amann, and G. Mayer, “Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease,” BMC Nephrology, vol. 15, no. 43, pp. 1–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Deng, X. Zhang, and N. Li, “Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry,” Journal of Chromatography B, vol. 808, no. 2, pp. 269–277, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Hakim, Y. Y. Broza, O. Barash et al., “Volatile organic compounds of lung cancer and possible biochemical pathways,” Chemical Reviews, vol. 112, no. 11, pp. 5949–5966, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Buszewski, A. Ulanowska, T. Kowalkowski, and K. Cieliski, “Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 3, pp. 573–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Phillips, J. Herrera, S. Krishnan, M. Zain, J. Greenberg, and R. N. Cataneo, “Variation in volatile organic compounds in the breath of normal humans,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 729, no. 1-2, pp. 75–88, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Kwak and G. Preti, “Volatile disease biomarkers in breath: a critique,” Current Pharmaceutical Biotechnology, vol. 12, no. 7, pp. 1067–1074, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Di Francesco, R. Fuoco, M. G. Trivella, and A. Ceccarini, “Breath analysis: trends in techniques and clinical applications,” Microchemical Journal, vol. 79, no. 1-2, pp. 405–410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Kischkel, W. Miekisch, A. Sawacki et al., “Breath biomarkers for lung cancer detection and assessment of smoking related effects—confounding variables, influence of normalization and statistical algorithms,” Clinica Chimica Acta, vol. 411, no. 21-22, pp. 1637–1644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. C. di Natale, A. Macagnano, E. Martinelli et al., “Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors,” Biosensors and Bioelectronics, vol. 18, no. 10, pp. 1209–1218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. R. F. Machado, “Identifying chronic obstructive pulmonary disease and asthma by exhaled breath analysis: does the (e)Nose know?” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 11, pp. 1038–1039, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Phillips, “Method for the collection and assay of volatile organic compounds in breath,” Analytical Biochemistry, vol. 247, no. 2, pp. 272–278, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. J. D. Pleil, M. A. Stiegel, and T. H. Risby, “Clinical breath analysis: discriminating between human endogenous compounds and exogenous (environmental) chemical confounders,” Journal of Breath Research, vol. 7, no. 1, Article ID 017107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Manolis, “The diagnostic potential of breath analysis,” Clinical Chemistry, vol. 29, no. 1, pp. 5–15, 1983. View at Google Scholar · View at Scopus
  38. P. Montuschi, “Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications,” Therapeutic Advances in Respiratory Disease, vol. 1, no. 1, pp. 5–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Miekisch, S. Kischkel, A. Sawacki, T. Liebau, M. Mieth, and J. K. Schubert, “Impact of sampling procedures on the results of breath analysis,” Journal of Breath Research, vol. 2, no. 2, Article ID 026007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. K.-H. Kim, S. A. Jahan, and E. Kabir, “A review of breath analysis for diagnosis of human health,” TrAC: Trends in Analytical Chemistry, vol. 33, pp. 1–8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Alonso and J. M. Sanchez, “Analytical challenges in breath analysis and its application to exposure monitoring,” TrAC—Trends in Analytical Chemistry, vol. 44, pp. 78–89, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Beauchamp, “Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath,” Journal of Breath Research, vol. 5, no. 3, Article ID 037103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Poulin and K. Krishnan, “A mechanistic algorithm for predicting blood: air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin,” Toxicology and Applied Pharmacology, vol. 136, no. 1, pp. 131–137, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. C. L. Silva, M. Passos, and J. S. Câmara, “Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry,” British Journal of Cancer, vol. 105, no. 12, pp. 1894–1904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Horváth, Z. Lázár, N. Gyulai, M. Kollai, and G. Losonczy, “Exhaled biomarkers in lung cancer,” European Respiratory Journal, vol. 34, no. 1, pp. 261–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Phillips, K. Gleeson, J. M. B. Hughes et al., “Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study,” The Lancet, vol. 353, no. 9168, pp. 1930–1933, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. A. A. Aksenov, A. Gojova, W. Zhao et al., “Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's ‘chemical door fingerprint’,” ChemBioChem, vol. 13, no. 7, pp. 1053–1059, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Bunge, N. Araghipour, T. Mikoviny et al., “On-line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry,” Applied and Environmental Microbiology, vol. 74, no. 7, pp. 2179–2186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. C. E. Garner, S. Smith, B. D. L. Costello et al., “Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease,” The FASEB Journal, vol. 21, no. 8, pp. 1675–1688, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Zhu, H. D. Bean, Y.-M. Kuo, and J. E. Hill, “Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry,” Journal of Clinical Microbiology, vol. 48, no. 12, pp. 4426–4431, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Syhre, L. Manning, S. Phuanukoonnon, P. Harino, and S. T. Chambers, “The scent of Mycobacterium tuberculosis—part II breath,” Tuberculosis, vol. 89, no. 4, pp. 263–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. J.-N. Cornu, G. Cancel-Tassin, V. Ondet, C. Girardet, and O. Cussenot, “Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis,” European Urology, vol. 59, no. 2, pp. 197–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Horvath, G. A. K. Järverud, S. Järverud, and I. Horváth, “Human ovarian carcinomas detected by specific odor,” Integrative Cancer Therapies, vol. 7, no. 2, pp. 76–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Horvath, H. Andersson, and G. Paulsson, “Characteristic odour in the blood reveals ovarian carcinoma,” BMC Cancer, vol. 10, article 643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. M. McCulloch, T. Jezierski, M. Broffman, A. Hubbard, K. Turner, and T. Janecki, “Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers,” Integrative Cancer Therapies, vol. 5, no. 1, pp. 30–39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. D. P. Pickel, G. P. Manucy, D. B. Walker, S. B. Hall, and J. C. Walker, “Evidence for canine olfactory detection of melanoma,” Applied Animal Behaviour Science, vol. 89, no. 1-2, pp. 107–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. C. M. Willis, S. M. Church, C. M. Guest et al., “Olfactory detection of human bladder cancer by dogs: proof of principle study,” British Medical Journal, vol. 329, no. 7468, pp. 712–714, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Matsumura, M. Opiekun, H. Oka et al., “Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer,” PLoS ONE, vol. 5, no. 1, Article ID e8819, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Deng, X. Zhang, and N. Li, “Development of headspace solid-phase microextraction with on-fiber derivatization for determination of hexanal and heptanal in human blood,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 813, no. 1-2, pp. 47–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Yazdanpanah, X. Luo, R. Lau, M. Greenberg, L. J. Fisher, and D. C. Lehotay, “Cytotoxic aldehydes as possible markers for childhood cancer,” Free Radical Biology & Medicine, vol. 23, no. 6, pp. 870–878, 1997. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Xue, L. Dong, S. Zhang et al., “Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 22, no. 8, pp. 1181–1186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. K. A. Kouremenos, M. Johansson, and P. J. Marriott, “Advances in gas chromatographic methods for the identification of biomarkers in cancer,” Journal of Cancer, vol. 3, no. 1, pp. 404–420, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. C. L. Silva, M. Passos, and J. S. Câmara, “Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers—a powerful strategy for breast cancer diagnosis,” Talanta, vol. 89, pp. 360–368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Huang, S. Kumar, N. Abbassi-Ghadi, P. Španěl, D. Smith, and G. B. Hanna, “Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer,” Analytical Chemistry, vol. 85, no. 6, pp. 3409–3416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Guadagni, N. Miraglia, A. Simonelli et al., “Solid-phase microextraction-gas chromatography-mass spectrometry method validation for the determination of endogenous substances: urinary hexanal and heptanal as lung tumor biomarkers,” Analytica Chimica Acta, vol. 701, no. 1, pp. 29–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Jobu, C. Sun, S. Yoshioka et al., “Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer,” Biological and Pharmaceutical Bulletin, vol. 35, no. 4, pp. 639–642, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. G. A. Mills and V. Walker, “Headspace solid-phase microextraction procedures for gas chromatographic analysis of biological fluids and materials,” Journal of Chromatography A, vol. 902, no. 1, pp. 267–287, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. León, J. C. García-Cañaveras, M. T. Donato, and A. Lahoz, “Mammalian cell metabolomics: experimental design and sample preparation,” Electrophoresis, vol. 34, no. 19, pp. 2762–2775, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Zimmermann, M. Hartmann, M. P. Moyer, J. Nolte, and J. I. Baumbach, “Determination of volatile products of human colon cell line metabolism by GC/MS analysis,” Metabolomics, vol. 3, no. 1, pp. 13–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Kwak, M. Gallagher, M. H. Ozdener et al., “Volatile biomarkers from human melanoma cells,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 931, pp. 90–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Amal, L. Ding, B.-B. Liu et al., “The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs),” International Journal of Nanomedicine, vol. 7, pp. 4135–4146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Sponring, W. Filipiak, T. Mikoviny et al., “Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro,” Anticancer Research, vol. 29, no. 1, pp. 419–426, 2009. View at Google Scholar · View at Scopus
  73. O. Barash, N. Peled, U. Tisch, P. A. Bunn, F. R. Hirsch, and H. Haick, “Classification of lung cancer histology by gold nanoparticle sensors,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 5, pp. 580–589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Brunner, W. Szymczak, V. Höllriegl et al., “Discrimination of cancerous and non-cancerous cell lines by headspace-analysis with PTR-MS,” Analytical and Bioanalytical Chemistry, vol. 397, no. 6, pp. 2315–2324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Sulé-Suso, A. Pysanenko, P. Španěl, and D. Smith, “Quantification of acetaldehyde and carbon dioxide in the headspace of malignant and non-malignant lung cells in vitro by SIFT-MS,” Analyst, vol. 134, no. 12, pp. 2419–2425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Yu, D. Wang, L. Wang, P. Wang, Y. Hu, and K. Ying, “Detection of lung cancer with volatile organic biomarkers in exhaled breath and lung cancer cells,” in Proceedings of the 13rd International Symposium on Olfaction and Electronic Nose, M. Prado and G. G. Sberveglieri, Eds., pp. 198–201, AIP Conference Proceedings, Brescia, Italy, April 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. J. He, P. M.-L. Sinues, F. M. Hollmén, X. Li, M. Detmar, and R. Zenobi, “Fingerprinting breast cancer vs. normal mammary cells by mass spectrometric analysis of volatiles,” Scientific Reports, vol. 4, no. 5196, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  78. J. Chen, W. Wang, S. Lv et al., “Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations,” Analytica Chimica Acta, vol. 650, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Hanai, K. Shimono, H. Oka, Y. Baba, K. Yamazaki, and G. K. Beauchamp, “Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice,” Cancer Cell International, vol. 12, article 7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. W. Filipiak, A. Sponring, A. Filipiak et al., “TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 1, pp. 182–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. A. V. Rutter, T. W. E. Chippendale, Y. Yang, P. Španěl, D. Smith, and J. Sulé-Suso, “Quantification by SIFT-MS of acetaldehyde released by lung cells in a 3D model.,” The Analyst, vol. 138, no. 1, pp. 91–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Smith, T. Wang, J. Sulé-Suso, P. Španěl, and A. El Haj, “Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 17, no. 8, pp. 845–850, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Hughes, D. Marshall, Y. Reid, H. Parkes, and C. Gelber, “The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?” BioTechniques, vol. 43, no. 5, pp. 575–586, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. C. A. Acevedo, E. Y. Sánchez, J. G. Reyes, and M. E. Young, “Volatile organic compounds produced by human skin cells,” Biological Research, vol. 40, no. 3, pp. 347–355, 2007. View at Google Scholar · View at Scopus
  85. C. A. Acevedo, E. Y. Sanchez, J. G. Reyes, and M. E. Young, “Volatile profiles of human skin cell cultures in different degrees of senescence,” Journal of Chromatography B, vol. 878, no. 3-4, pp. 449–455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Hartmann, D. Zimmermann, and J. Nolte, “Changes of the metabolism of the colon cancer cell line SW-480 under serum-free and serum-reduced growth conditions,” In Vitro Cellular & Developmental Biology—Animal, vol. 44, no. 10, pp. 458–463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. J. S. Pyo, H. K. Ju, J. H. Park, and S. W. Kwon, “Determination of volatile biomarkers for apoptosis and necrosis by solid-phase microextraction–gas chromatography/mass spectrometry: a pharmacometabolomic approach to cisplatin's cytotoxicity to human lung cancer cell lines,” Journal of Chromatography B, vol. 876, no. 2, pp. 170–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Bajtarevic, C. Ager, M. Pienz et al., “Noninvasive detection of lung cancer by analysis of exhaled breath,” BMC Cancer, vol. 9, article 348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. U. Kalluri, M. Naiker, and M. A. Myers, “Cell culture metabolomics in the diagnosis of lung cancer—the influence of cell culture conditions,” Journal of Breath Research, vol. 8, no. 2, Article ID 027109, pp. 1–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Vaupel, “Tumor microenvironmental physiology and its implications for radiation oncology,” Seminars in Radiation Oncology, vol. 14, no. 3, pp. 198–206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. W. Filipiak, A. Filipiak, A. Sponring et al., “Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers,” Journal of Breath Research, vol. 8, no. 2, Article ID 027111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. D. Poli, M. Goldoni, A. Caglieri et al., “Breath analysis in non small cell lung cancer patients after surgical tumour resection,” Acta Biomedica de l'Ateneo Parmense, vol. 79, no. 1, pp. 64–72, 2008. View at Google Scholar · View at Scopus
  93. D. Poli, P. Carbognani, M. Corradi et al., “Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study,” Respiratory Research, vol. 6, article 71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Phillips, N. Altorki, J. H. M. Austin et al., “Prediction of lung cancer using volatile biomarkers in breath,” Cancer Biomarkers, vol. 3, no. 2, pp. 95–109, 2007. View at Google Scholar · View at Scopus
  95. M. Phillips, N. Altorki, J. H. M. Austin et al., “Detection of lung cancer using weighted digital analysis of breath biomarkers,” Clinica Chimica Acta, vol. 393, no. 2, pp. 76–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Fuchs, C. Loeseken, J. K. Schubert, and W. Miekisch, “Breath gas aldehydes as biomarkers of lung cancer,” International Journal of Cancer, vol. 126, no. 11, pp. 2663–2670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. E. M. Gaspar, A. F. Lucena, J. D. da Costa, and H. C. das Neves, “Organic metabolites in exhaled human breath—a multivariate approach for identification of biomarkers in lung disorders,” Journal of Chromatography A, vol. 1216, no. 14, pp. 2749–2756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Phillips, R. N. Cataneo, A. R. C. Cummin et al., “Detection of lung cancer with volatile markers in the breath,” Chest, vol. 123, no. 6, pp. 2115–2123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Yu, L. Xu, and P. Wang, “Solid phase microextraction for analysis of alkanes and aromatic hydrocarbons in human breath,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 826, no. 1-2, pp. 69–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Toyokuni, “Molecular mechanisms of oxidative stress-induced carcinogenesis: from epidemiology to oxygenomics,” IUBMB Life, vol. 60, no. 7, pp. 441–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Eggink, M. Wijtmans, A. Kretschmer et al., “Targeted LC-MS derivatization for aldehydes and carboxylic acids with a new derivatization agent 4-APEBA,” Analytical and Bioanalytical Chemistry, vol. 397, no. 2, pp. 665–675, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. F. J. Romero, F. Bosch-Morell, M. J. Romero et al., “Lipid peroxidation products and antioxidants in human disease,” Environmental Health Perspectives, vol. 106, no. 5, pp. 1229–1234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  103. C. M. Kneepkers, G. Lepage, and C. C. Roy, “The potential of the hydrocarbon breath test as a measure of lipid peroxidation,” Free Radical Biology and Medicine, vol. 17, no. 2, pp. 127–160, 1994. View at Google Scholar
  104. T. Mitsui and T. Kondo, “Inadequacy of theoretical basis of breath methylated alkane contour for assessing oxidative stress,” Clinica Chimica Acta, vol. 333, no. 1, p. 91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  105. D. A. Cancilla and S. S. Que Hee, “O-(2,3,4,5,6-pentafluorophenyl)methylhydroxylamine hydrochloride: a versatile reagent for the determination of carbonyl-containing compounds,” Journal of Chromatography A, vol. 627, no. 1-2, pp. 1–16, 1992. View at Publisher · View at Google Scholar · View at Scopus
  106. N. Li, C. Deng, X. Yin, N. Yao, X. Shen, and X. Zhang, “Gas chromatography–mass spectrometric analysis of hexanal and heptanal in human blood by headspace single-drop microextraction with droplet derivatization,” Analytical Biochemistry, vol. 342, no. 2, pp. 318–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Lili, H. Xu, D. Song, Y. Cui, S. Hu, and G. Zhang, “Analysis of volatile aldehyde biomarkers in human blood by derivatization and dispersive liquid-liquid microextraction based on solidification of floating organic droplet method by high performance liquid chromatography,” Journal of Chromatography A, vol. 1217, no. 16, pp. 2365–2370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. D. Poli, M. Goldoni, M. Corradi et al., “Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 27, pp. 2643–2651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. H. Kataoka and K. Saito, “Recent advances in SPME techniques in biomedical analysis,” Journal of Pharmaceutical and Biomedical Analysis, vol. 54, no. 5, pp. 926–950, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. H. Kataoka, “Current developments and future trends in solid-phase microextraction techniques for pharmaceutical and biomedical analyses,” Analytical Sciences, vol. 27, no. 9, pp. 893–905, 2011. View at Publisher · View at Google Scholar · View at Scopus
  111. Z. Zhang, Y. Ma, and G. Li, “Progress on the analytical methodology for biological volatile organic compounds,” Analytical Methods, vol. 5, no. 1, pp. 20–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. B. Bojko and J. Pawliszyn, “The benefits of using solid-phase microextraction as a greener sample preparation technique,” Bioanalysis, vol. 4, no. 11, pp. 1263–1265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. K. K. Kleeberg, N. Dobberstein, N. Hinrichsen, A. Muller, P. Weber, and H. Steinhart, “Sampling procedures with special focus on automatization,” in Advances in Food Diagnostics, L. M. L. Nollet and F. Toldar, Eds., pp. 253–294, Blackwell, Oxford, UK, 2007. View at Google Scholar
  114. B. Kolb, “Headspace sampling with capillary columns,” Journal of Chromatography A, vol. 842, no. 1-2, pp. 163–205, 1999. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Pawliszyn, “Theory of solid-phase microextraction,” Journal of Chromatographic Science, vol. 38, no. 7, pp. 270–278, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. R. E. Shirey, “SPME commercial devices and fibre coatings,” in Handbook of Solid Phase Microextraction, J. Pawliszyn, Ed., pp. 87–115, Chemical Industry Press, Waterloo, Canada, 2009. View at Google Scholar
  117. T. Ligor, M. Ligor, A. Amann et al., “The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS,” Journal of Breath Research, vol. 2, no. 4, Article ID 046006, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Hyšpler, Š. Crhová, J. Gasparič, Z. Zadák, M. Čížková, and V. Balasová, “Determination of isoprene in human expired breath using solid-phase microextraction and gas chromatography-mass spectrometry,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 739, no. 1, pp. 183–190, 2000. View at Publisher · View at Google Scholar · View at Scopus
  119. T. Ligor, J. Szeliga, M. Jackowski, and B. Buszewski, “Preliminary study of volatile organic compounds from breath and stomach tissue by means of solid phase microextraction and gas chromatography-mass spectrometry,” Journal of Breath Research, vol. 1, no. 1, Article ID 016001, 2007. View at Publisher · View at Google Scholar
  120. C. Duan, Z. Shen, D. Wu, and Y. Guan, “Recent developments in solid-phase microextraction for on-site sampling and sample preparation,” TrAC—Trends in Analytical Chemistry, vol. 30, no. 10, pp. 1568–1574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. E. A. S. Silva, S. Risticevic, and J. Pawliszyn, “Recent trends in SPME concerning sorbent materials, configurations and in vivo applications,” TrAC Trends in Analytical Chemistry, vol. 43, pp. 24–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. P. Mochalski, A. Sponring, J. King, K. Unterkofler, J. Troppmair, and A. Amann, “Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro,” Cancer Cell International, vol. 13, no. 1, article 72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. O. Barash, N. Peled, F. R. Hirsch, and H. Haick, “Sniffing the unique ‘Odor Print’ of non-small-cell lung cancer with gold nanoparticles,” Small, vol. 5, no. 22, pp. 2618–2624, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. B. Vrana, G. A. Mills, I. J. Allan et al., “Passive sampling techniques for monitoring pollutants in water,” Trends in Analytical Chemistry, vol. 24, no. 10, pp. 845–868, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. H. W. Shin, B. J. Umber, S. Meinardi et al., “Acetaldehyde and hexanaldehyde from cultured white cells,” Journal of Translational Medicine, vol. 7, article 31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. Y. Adiguzel and H. Kulah, “Breath sensors for lung cancer diagnosis,” Biosensors and Bioelectronics, vol. 65, pp. 121–138, 2015. View at Publisher · View at Google Scholar
  127. G. Konvalina and H. Haick, “Sensors for breath testing: from nanomaterials to comprehensive disease detection,” Accounts of Chemical Research, vol. 47, no. 1, pp. 66–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  128. W. Li, H. Y. Liu, Z. R. Jia et al., “Advances in the early detection of lung cancer using analysis of volatile organic compounds from imaging to sensors,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4377–4384, 2014. View at Publisher · View at Google Scholar
  129. M. Righettoni, A. Amann, and S. E. Pratsinis, “Breath analysis by nanostructured metal oxides as chemo-resistive gas sensors,” Materials Today, vol. 18, no. 3, pp. 163–171, 2015. View at Publisher · View at Google Scholar
  130. M. K. Nakhleh, Y. Y. Broza, and H. Haick, “Monolayer-capped gold nanoparticles for disease detection from breath,” Nanomedicine, vol. 9, no. 13, pp. 1991–2002, 2014. View at Publisher · View at Google Scholar
  131. C. Di Natale, R. Paolesse, E. Martinelli, and R. Capuano, “Solid-state gas sensors for breath analysis: a review,” Analytica Chimica Acta, vol. 824, pp. 1–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. Y. Broza and H. Haick, “Nanomaterial-based sensors for detection of disease by volatile organic compounds,” Nanomedicine, vol. 8, no. 5, pp. 785–806, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. A. Wehinger, A. Schmid, S. Mechtcheriakov et al., “Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas,” International Journal of Mass Spectrometry, vol. 265, no. 1, pp. 49–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. I. Kushch, K. Schwarz, L. Schwentner et al., “Compounds enhanced in a mass spectrometric profile of smokers' exhaled breath versus non-smokers as determined in a pilot study using PTR-MS,” Journal of Breath Research, vol. 2, no. 2, Article ID 026002, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. W. Lindinger, A. Hansel, and A. Jordan, “On-line monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS). Medical applications, food control and environmental research,” International Journal of Mass Spectrometry and Ion Processes, vol. 173, no. 3, pp. 191–241, 1998. View at Publisher · View at Google Scholar · View at Scopus
  136. D. Smith and P. Španěl, “Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis,” Mass Spectrometry Reviews, vol. 24, no. 5, pp. 661–700, 2005. View at Publisher · View at Google Scholar · View at Scopus
  137. Ionicon Analytik, “PTR-QMS 300” on the IONICON Analytik Website, 2013, http://www.ionicon.com/products/ptr-ms/ptrqms/cptrms.html.
  138. M. Westhoff, P. Litterst, L. Freitag, W. Urfer, S. Bader, and J.-I. Baumbach, “Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study,” Thorax, vol. 64, no. 9, pp. 744–748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. K. Darwiche, J. I. Baumbach, U. Sommerwerck, H. Teschler, and L. Freitag, “Bronchoscopically obtained volatile biomarkers in lung cancer,” Lung, vol. 189, no. 6, pp. 445–452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. A. Ulanowska, M. Ligor, A. Amann, and B. Buszewski, “Determination of volatile organic compounds in exhaled breath by ion mobility spectrometry,” Chemia Analityczna, vol. 53, no. 6, pp. 953–965, 2008. View at Google Scholar · View at Scopus
  141. H. Lord, Y. Yu, A. Segal, and J. Pawliszyn, “Breath analysis and monitoring by membrane extraction with sorbent interface,” Analytical Chemistry, vol. 74, no. 21, pp. 5650–5657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  142. H. Handa, A. Usuba, S. Maddula, J. I. Baumbach, M. Mineshita, and T. Miyazawa, “Exhaled breath analysis for lung cancer detection using ion mobility spectrometry,” PLoS ONE, vol. 9, no. 12, Article ID e114555, 2014. View at Publisher · View at Google Scholar
  143. G. Peng, M. Hakim, Y. Y. Broza et al., “Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors,” British Journal of Cancer, vol. 103, no. 4, pp. 542–551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  144. C. Hagleitner, A. Hierlemann, D. Lange et al., “Smart single-chip gas sensor microsystem,” Nature, vol. 414, no. 6861, pp. 293–296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  145. S. Dragonieri, J. T. Annema, R. Schot et al., “An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD,” Lung Cancer, vol. 64, no. 2, pp. 166–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. P. J. Mazzone, J. Hammel, R. Dweik et al., “Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array,” Thorax, vol. 62, no. 7, pp. 565–568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  147. T. Khalid, P. White, B. D. L. Costello et al., “A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace,” PLoS ONE, vol. 8, no. 7, Article ID e69602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  148. F. Röck, N. Barsan, and U. Weimar, “Electronic nose: current status and future trends,” Chemical Reviews, vol. 108, no. 2, pp. 705–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. D. Gao, J. Ji, J. Gong, and C. Cai, “Quantitative analysis of different volatile organic compounds using an improved electronic nose,” Measurement Science and Technology, vol. 23, no. 10, Article ID 105103, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. E. H. Oh, H. S. Song, and T. H. Park, “Recent advances in electronic and bioelectronic noses and their biomedical applications,” Enzyme and Microbial Technology, vol. 48, no. 6-7, pp. 427–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. F. Biasioli, C. Yeretzian, T. D. Märk, J. Dewulf, and H. van Langenhove, “Direct-injection mass spectrometry adds the time dimension to (B)VOC analysis,” Trends in Analytical Chemistry, vol. 30, no. 7, pp. 1003–1017, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. C. Di Natale, A. Macagnano, E. Martinelli et al., “Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors,” Biosensors and Bioelectronics, vol. 18, no. 10, pp. 1209–1218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  153. N. Peled, M. Hakim, P. A. Bunn et al., “Non-invasive breath analysis of pulmonary nodules,” Journal of Thoracic Oncology, vol. 7, no. 10, pp. 1528–1533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  154. A. Bartolazzi, M. Santonico, G. Pennazza et al., “A sensor array and GC study about VOCs and cancer cells,” Sensors and Actuators, B: Chemical, vol. 146, no. 2, pp. 483–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. S. Kato, P. J. Burke, D. J. Fenick, D. J. Taatjes, V. M. Bierbaum, and T. H. Koch, “Mass spectrometric measurement of formaldehyde generated in breast cancer cells upon treatment with anthracycline antitumor drugs,” Chemical Research in Toxicology, vol. 13, no. 6, pp. 509–516, 2000. View at Publisher · View at Google Scholar · View at Scopus
  156. S. Kato, P. J. Burke, T. H. Koch, and V. M. Bierbaum, “Formalehyde in human cancer cells: detection by preconcentration-chemical ionization mass spectrometry,” Analytical Chemistry, vol. 73, no. 13, pp. 2992–2997, 2001. View at Publisher · View at Google Scholar · View at Scopus
  157. S. Kato, G. C. Post, V. M. Bierbaum, and T. H. Koch, “Chemical ionization mass spectrometric determination of acrolein in human breast cancer cells,” Analytical Biochemistry, vol. 305, no. 2, pp. 251–259, 2002. View at Publisher · View at Google Scholar · View at Scopus